Watch BHC. Know when insiders buy.
One email the day a filing lands. Free.
Work order
32
FLAG · insiders 38, shorts 25
Insiders, 90 days
−$259K
net selling · 0 buys, 1 sell
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.5BP/E —DIV YIELD —FCF YIELD 58.33%REV TTM $10.9B +10.1%NET INCOME −$1.1B −1220.4%NET DEBT $18.9B52W 4.43 – 7.90SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $2.9B | +12.7% | — | $740M | $258M | +74.3% | 0.68 | $670M | $77M | $593M | Jul 30 |
| Q1 2026 · Mar 31 | $2.5B | +11.7% | — | −$950M | −$1.4B | — | -3.82 | $230M | $109M | $121M | Apr 30 |
| Q4 2025 · Dec 31derived | $2.8B | +9.3% | — | $474M | −$112M | −220.4% | -0.30 | $495M | $92M | $403M | Feb 19 |
| Q3 2025 · Sep 30 | $2.7B | +6.8% | — | $619M | $179M | — | 0.48 | $405M | $91M | $314M | Oct 30 |
| Q2 2025 · Jun 30 | $2.5B | +5.3% | — | $444M | $148M | +1380.0% | 0.40 | $289M | $99M | $190M | Jul 30 |
| Q1 2025 · Mar 31 | $2.3B | +4.9% | — | $276M | −$58M | — | -0.16 | $211M | $115M | $96M | Apr 30 |
| Q4 2024 · Dec 31derived | $2.6B | +6.3% | — | $558M | $93M | — | 0.25 | $601M | $106M | $495M | Feb 19 |
| Q3 2024 · Sep 30 | $2.5B | +12.2% | — | $318M | −$85M | — | -0.23 | $405M | $71M | $334M | Oct 30 |
| Q2 2024 · Jun 30 | $2.4B | — | — | $389M | $10M | — | 0.03 | $380M | $78M | $302M | Jul 31 |
| Q1 2024 · Mar 31 | $2.2B | — | — | $281M | −$64M | — | -0.17 | $211M | $82M | $129M | May 1 |
| Q4 2023 · Dec 31derived | $2.4B | — | — | $362M | −$39M | — | -0.10 | $390M | $98M | $292M | Feb 19 |
| Q3 2023 · Sep 30 | $2.2B | — | — | $14M | −$378M | — | -1.03 | $282M | $42M | $240M | Oct 31 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $10.3B | — | $1.8B | $157M | 1.5% | 0.42 | $1.4B | $397M | $1B | — | — |
| FY2024 · to Dec 31 | $9.6B | — | $1.5B | −$46M | -0.5% | -0.13 | $1.6B | $337M | $1.3B | — | — |
| FY2023 · to Dec 31 | $8.8B | — | $963M | −$592M | -6.8% | -1.62 | $1B | $215M | $817M | — | — |
| FY2022 · to Dec 31 | $8.1B | — | $454M | −$225M | -2.8% | -0.62 | −$728M | $218M | −$946M | — | — |
| FY2021 · to Dec 31 | $8.4B | — | $450M | −$948M | -11.2% | -2.64 | $1.4B | $269M | $1.2B | — | — |
| FY2020 · to Dec 31 | $8B | — | $676M | −$560M | -7.0% | -1.58 | $1.1B | $302M | $809M | — | — |
Every number comes from Bausch Health Companies Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.